Cassava Sciences' stock is highly disputed due to conflicting opinions on the science behind its drug candidate, but outside research supports its apparent drug effect. Biomarkers show strong ...

These are material risks—but they are risks inherent to the business model, not proof of strategic obsolescence.

Dr. Hoau-Yan Wang, a key collaborator, was indicted for fraud related to NIH grant applications. Cassava has extended simufilam trials by up to 36 months to gather more long-term data. Cassava has ...

Cassava (also called yuca, Brazilian arrowroot and manioc) is a starchy root vegetable that’s grown globally. It’s a versatile ingredient that can be found in a wide variety of dishes, and on top of ...

Raw cassava contains cyanide, which is toxic to ingest, so it is vital to prepare it correctly. Also, there are two types of cassava: sweet and bitter. Bitter cassava is hardier but has a much higher ...

Technology company Cassava Technologies and intelligent network platform company AXON Networks have announced a strategic partnership to co-develop, deploy and manage what is described as Africa’s ...

Cassava Sciences SAVA, a clinical-stage biotech focusing on developing novel products to detect and treat neurodegenerative diseases, such as Alzheimer’s disease (AD), is expected to report ...